Ivor-Lewis手术治疗食管癌的近期临床疗效与术后感染预防  

Recent clinical efficacy of Ivor-Lewis surgery in treatment of esophageal cancer and prevention of postoperative infections

作　　者：陈晟[1] 

机构地区：[1]浙江省肿瘤医院胸外科,浙江杭州310022

出　　处：《中华医院感染学杂志》2013年第5期1044-1046,共3页Chinese Journal of Nosocomiology

摘　　要：目的分析Ivor-Lewis手术治疗食管癌的近期临床疗效并探讨术后感染情况,为临床预防与治疗提供参考。方法选取医院接受手术治疗的食管癌患者94例,其中50例患者予Ivor-Lewis手术治疗,作为观察组;另44例予Sweet手术治疗,作为对照组,比较两组近期临床疗效和术后感染情况。结果观察组胃肠功能恢复时间为(4.56±1.71)d,明显优于对照组(6.16±2.32)d,两组比较差异有统计学意义(t=5.42,P<0.05)。观察组淋巴结清扫数量为(9.8±4.6)个,明显优于对照组(6.5±3.2)个,两组比较差异有统计学意义(t=4.62,P<0.05);观察组肺部感染患者2例,发生率为4.00%,优于对照组的5例,发生率11.36%,两组差异有统计学意义(χ2=6.17,P<0.05);观察组脓胸患者1例,发生率2.00%,优于对照组的4例,发生率9.09%,两组差异有统计学意义(χ2=5.43,P<0.05)。结论 Ivor-Lewis手术治疗食管癌的近期临床疗效效果良好,可有效改善预后,降低肺部并发症的发生率。OBJECTIVE To analyze recent clinical efficacy of the Ivor-Lewis surgery in treatment of esophageal cancer and to investigate the postoperative infections so as to provide reference for the clinical prevention and treatment.METHODS A total of 94 cases of esophageal cancer patients,who treated with surgery in the hospital,were collected as the study objects,among which 50 patients who underwent the Ivor-Lewis surgery were set as the observation group,44 patients who underwent Sweet surgery as the control group;the recent clinical efficacies and the incidence of postoperative infections were observed and compared.RESULTS The recovery of gastrointestinal function of the observation group was（4.56±1.71） d,significantly better than（6.16±2.32） d of the control group,the difference was statistically significant（t=5.42,P0.05）.The number of lymph node dissection of the observation group was（9.8±4.6） significantly better than（6.5±3.2） of the control group,the difference was statistically significant（t=4.62,P0.05）.The pulmonary infections occurred in 2 cases of the observation group with the incidence rate of 4.00%,significantly lower than 11.36%（5 cases） of the control group,the difference was statistically significant（χ2 = 6.17,P0.05）.The empyema occurred in 1 case of the observation group with the incidence rate of 2.00%,significantly lower than 9.09%（4 cases） of the control group,the difference was statistically significant（χ2= 5.43,P0.05）.CONCLUSION Ivor-Lewis surgery can achieve good clinical efficacy in the treatment of esophageal cancer,improve the prognosis effectively,and reduce the incidence of pulmonary complications.

关 键 词：IVOR-LEWIS手术 食管癌 临床疗效 感染预防 

分 类 号：R619[医药卫生—外科学]